RxDoctor Payments Data

Michele Evans, NP

Adult Health · Richmond, VANPI 1760804546

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.6% of the total across 306 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,719 and has fallen 52.2% since, to $1,299 in 2025. Among adult health clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,234in general payments, 2019–2025

Across 306 payments — averaging $23.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$987
  • AstraZeneca$862
  • GSK$792
  • Sanofi$493
  • Novartis$409
  • Takeda Pharmaceuticals U.S.A., Inc.$394
  • plus $3K from 24 others

What the payments were for

  • Food & beverage$7,13499%
  • Education$1001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,234 in reported general payments places this provider in the 90th percentile of 368 adult health providers in Virginia.

See all adult health providers in Virginia

Medicare billing

Part B allowed, 2024
$71,794
Medicare patients
713
Services billed
874

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Montelukast Sodium11$104
Clonazepam19$70

Paid to pharmacies, not to this prescriber.

Other adult health in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →